Hb concentration (g/L)1 | Anemia prevalence (Hb <110 g/L)1 | Bayley MDI (points)2 | Bayley PDI (points)2 | |||||
---|---|---|---|---|---|---|---|---|
Trial arms compared | Difference (95% CI) | P value | Marginal effect (95% CI) | P- value | Difference (95% CI) | P- value | Marginal effect (95% CI) | P- value |
Free vs control after 6 months follow-up3 | 1.840 (− 0.189–3.868) | 0.075 | − 0.048 (− 0.129–0.034) | 0.252 | 3.025 (0.443–5. 606) | 0.022* | − 1.624 (− 5.166–1.918) | 0.368 |
Free vs control after 12 months3 | − 0.502 (− 2.760–1.757) | 0.662 | 0.026 (− 0.056–0.108) | 0.535 | 1.978 (− 0.899–4.855) | 0.177 | − 0.846 (− 3.807–2.114) | 0.574 |
Free vs control after 18 months3 | − 0.718 (− 2.930–1.494) | 0.524 | 0.026 (− 0.054–0.107) | 0.523 | 2.808 (− 0.159–5.774) | 0.064 | − 0.162 (− 2.785–2.419) | 0.902 |
Text vs control after 6 months4 | 1.715 (− 0.347–3.777) | 0.103 | − 0.069 (− 0.146–0.007) | 0.075 | 1.423 (− 1.184–4.030) | 0.284 | 1.061 (− 2.379–4.501) | 0.544 |
Text vs control after 12 months 4 | 0.266 (− 2.220–2.752) | 0.833 | 0.042 (− 0.046–0.129) | 0.348 | − 0.70 (− 3.788–2.389) | 0.656 | − 0.062 (− 2.886–2.763) | 0.966 |
Text vs control after 18 months 4 | 0.936 (−1.419–3.290) | 0.435 | − 0.027 (− 0.110–0.056) | 0.526 | − 0.776 (− 3.90–2.348) | 0.626 | 0.347 (− 2.600–3.294) | 0.817 |
R-squared | 0.14 | 0.10 | 0.27 | 0.21 | ||||
Observations | 6092 | 6092 | 6204 | 6186 |